ArticleScientific reports2025
Reformulation of soy sauce to reduce sodium content and assessment of manufacturer readiness, consumer acceptance, and shelf life.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Soy sauce is a major source of dietary sodium in Malaysia. Reformulating soy sauce to reduce its sodium content may help lower population salt intake. This study aimed to (1) assess sodium content of Malaysian soy sauces; (2) evaluate manufacturer readiness for reformulation; (3) develop reduced sodium soy sauce formulations; and (4) determine consumer acceptability and shelf life stability. A mixed-methods study was conducted in two phases: (1) needs assessment through sodium analysis of 102 soy sauces from supermarkets and interviews with 19 employees; and (2) development of reduced sodium soy sauce formulations, followed by consumer sensory testing (n = 52) and accelerated shelf life assessment. Salty (4987 ± 1429 mg/100 g) and light soy sauces (5710 ± 1488 mg/100 g) contained significantly higher sodium than sweet soy sauces (3368 ± 863 mg/100 g; p < 0.05). Manufacturers acknowledged the importance of salt reduction but cited barriers including consumer acceptance, regulatory requirements, costs, and limited research and development capacity. Among the reformulated products, soy sauce with 9% salt plus yeast extract (≈3600 mg sodium/100 g) was most preferred and remained shelf-stable for one year. Reformulation of soy sauce with lower sodium content is feasible without compromising safety or palatability. Wider adoption by manufacturers, supported by incentives and regulatory adjustments, could reduce population salt intake in Malaysia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.